Innovation1 Biotech Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q4 2014 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Innovation1 Biotech Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q4 2014 to Q3 2023.
  • Innovation1 Biotech Inc. Net Income (Loss) Attributable to Parent for the quarter ending August 31, 2023 was -$4.45M, a 88% increase year-over-year.
  • Innovation1 Biotech Inc. Net Income (Loss) Attributable to Parent for the twelve months ending August 31, 2023 was -$5.99M, a 85.4% increase year-over-year.
  • Innovation1 Biotech Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$5.99M, a 85.4% increase from 2022.
  • Innovation1 Biotech Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$40.9M, a 4031% decline from 2021.
  • Innovation1 Biotech Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $1.04M.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$5.99M -$4.45M +$32.8M +88% Jun 1, 2023 Aug 31, 2023 10-K 2024-01-17
Q2 2023 -$38.8M -$299K +$1.31M +81.4% Mar 1, 2023 May 31, 2023 10-K 2024-01-17
Q1 2023 -$40.1M -$603K +$1.18M +66.1% Dec 1, 2022 Feb 28, 2023 10-K 2024-01-17
Q4 2022 -$41.3M -$632K -$392K -163% Sep 1, 2022 Nov 30, 2022 10-K 2024-01-17
Q3 2022 -$40.9M -$37.2M -$36.4M -4166% Jun 1, 2022 Aug 31, 2022 10-K 2024-01-17
Q2 2022 -$4.5M -$1.61M -$2.41M -302% Mar 1, 2022 May 31, 2022 10-K 2024-01-17
Q1 2022 -$2.1M -$1.78M -$2.34M -419% Dec 1, 2021 Feb 28, 2022 10-K 2024-01-17
Q4 2021 $241K -$240K -$2.59K -1.09% Sep 1, 2021 Nov 30, 2021 10-K 2024-01-17
Q3 2021 $244K -$873K -$138K -18.8% Jun 1, 2021 Aug 31, 2021 10-K 2022-12-15
Q2 2021 $382K $796K +$742K +1369% Mar 1, 2021 May 31, 2021 10-K 2022-12-15
Q1 2021 -$360K $558K +$2.19M Dec 1, 2020 Feb 28, 2021 10-K 2022-12-15
Q4 2020 -$2.55M -$237K +$32.6K +12.1% Aug 31, 2020 Nov 30, 2020 10-Q 2022-04-15
Q3 2020 -$2.58M -$735K -$665K -959% Jun 1, 2020 Aug 31, 2020 10-K 2021-12-10
Q2 2020 -$1.91M $54.2K +$76.7K Mar 1, 2020 May 31, 2020 10-Q 2021-07-13
Q1 2020 -$1.99M -$1.63M -$1.64M -12490% Dec 1, 2019 Feb 29, 2020 10-Q 2021-04-14
Q4 2019 -$349K -$270K -$178K -195% Sep 1, 2019 Nov 30, 2019 10-Q 2021-07-13
Q3 2019 -$170K -$69.4K +$743K +91.5% Jun 1, 2019 Aug 31, 2019 10-K 2020-12-15
Q2 2019 -$913K -$22.5K -$3.49K -18.4% Mar 1, 2019 May 31, 2019 10-Q 2020-07-20
Q1 2019 -$909K $13.2K +$135K Nov 29, 2018 Feb 28, 2019 10-Q 2019-07-18
Q4 2018 -$1.04M -$91.4K -$68.6K -301% Sep 1, 2018 Nov 30, 2018 10-Q 2020-01-21
Q3 2018 -$976K -$812K -$797K -5253% Jun 1, 2018 Aug 31, 2018 10-Q 2019-07-18
Q2 2018 -$179K -$19K -$15K -377% Mar 1, 2018 May 31, 2018 10-Q 2019-07-18
Q1 2018 -$164K -$122K -$117K -2493% Dec 1, 2017 Feb 28, 2018 10-Q 2019-04-15
Q4 2017 -$46.6K -$22.8K -$10.8K -89.6% Sep 1, 2017 Nov 30, 2017 10-Q 2019-01-18
Q3 2017 -$35.9K -$15.2K -$8.17K -117% Jun 1, 2017 Aug 31, 2017 10-K/A 2018-01-19
Q2 2017 -$27.7K -$3.98K +$11K +73.5% Mar 1, 2017 May 31, 2017 10-Q 2017-07-24
Q1 2017 -$38.7K -$4.7K +$463 +8.97% Dec 1, 2016 Feb 28, 2017 10-Q 2017-04-14
Q4 2016 -$39.2K -$12K -$4.16K -53.1% Sep 1, 2016 Nov 30, 2016 10-Q 2017-01-17
Q3 2016 -$35K -$7K -$4.09K -140% Jun 1, 2016 Aug 31, 2016 10-K/A 2018-01-19
Q2 2016 -$30.9K -$15K -$11.2K -293% Mar 1, 2016 May 31, 2016 10-Q 2017-07-24
Q1 2016 -$19.7K -$5.16K -$3.13K -154% Dec 1, 2015 Feb 29, 2016 10-Q 2017-04-14
Q4 2015 -$16.6K -$7.84K -$2.09K -36.3% Sep 1, 2015 Nov 30, 2015 10-Q 2017-01-17
Q3 2015 -$14.5K -$2.91K Jun 1, 2015 Aug 31, 2015 10-K/A 2018-01-19
Q2 2015 -$3.82K Mar 1, 2015 May 31, 2015 10-Q 2016-10-07
Q1 2015 -$2.03K Dec 1, 2014 Feb 28, 2015 10-Q 2016-09-26
Q4 2014 -$5.76K Sep 1, 2014 Nov 30, 2014 10-Q 2016-02-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.